ATRC vs EW · rev $465.3M vs P/E 47, rev $1.39B
AtriCure Inc (ATRC) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
AtriCure Inc (ATRC) is a medical instruments & supplies company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported ATRC revenue for 2024-12-31 was $465.3M. Net income was -$44.7M. Revenue was up 16.5% from 2023-12-31 to 2024-12-31. ATRC currently screens at market cap $1.37B.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
ATRC currently screens at market cap $1.37B. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the ATRC and EW stock pages for the full models.
Not investment advice.